Share Dilution

BRODSKY & SMITH SHAREHOLDER UP

BALA CYNWYD, Pa., May 10, 2022 (GLOBE NEWSWIRE) — Brodsky & Smith reminds investors of the following investigations. If you own stock and would like to discuss the investigation, contact Jason Brodsky ([email protected]) or Marc Ackerman ([email protected]) at 855-576-4847. There is no cost or financial obligation for you.

Biohaven Pharmaceutical Holding Company Ltd. (- BHVN)

Under the terms of the agreement, Pfizer will acquire all outstanding shares of Biohaven not already owned by Pfizer for $148.50 per share in cash. Biohaven common stockholders, including Pfizer, will also receive 0.5 shares of New Biohaven, a new publicly traded company that will retain Biohaven’s non-CGRP development-stage pipeline compounds, per Biohaven common stock. The investigation focuses on whether Biohaven’s board breached its fiduciary duties to shareholders by failing to conduct due process and whether Pfizer is paying too little for the company.

Additional information can be found at https://www.brodskysmith.com/cases/biohaven-pharmaceutical-holding-company-ltd–bhvn/.

Tiga Acquisition Corp. (-TINV)

Under the terms of the agreement, Tiga, a special purpose acquisition company, will partner with Grindr, the #1 social network for the LGBTQ+ community, and make Grindr a publicly traded company. Under the terms of the agreement, Tiga shareholders will retain ownership of only 14% of the combined company. The investigation focuses on whether Tiga’s board breached its fiduciary duties to shareholders by failing to conduct due process, including diluting the stake in the merged company.

Additional information can be found at https://www.brodskysmith.com/cases/tiga-acquisition-corp–tinv/.

Lakeshore Acquisition I Corp. (Nasdaq-LAAA)

Under the terms of the agreement, Lakeshore, a special purpose acquisition company, will merge with ProSomnus Holdings Inc. (“ProSomnus”), a maker of patient-preferred medical devices for the treatment of obstructive sleep apnea, and will make ProSomnus a listed company. Under the terms of the agreement, Lakeshore shareholders will retain ownership of only 32% of the combined company. The investigation focuses on whether the Lakeshore board breached its fiduciary duties to shareholders by failing to conduct a fair process, including diluting the stake in the merged company.

Additional information can be found at https://www.brodskysmith.com/cases/lakeshore-acquisition-corp-nasdaq-laaa/.

Silicon Motion Technology Corporation (Nasdaq – SIMO)

Under the terms of the agreement, Silicon Motion will be acquired by MaxLinear, Inc. (Nasdaq – MXL). Under the terms of the merger agreement, each Silicon Motion American Depositary Share (“ADS”), which represents four shares of Silicon Motion common stock, will receive $93.54 in cash and 0.388 shares of MaxLinear common stock, for a total per ADS of $114.34. (based on MaxLinear’s closing price on May 4, 2022). The investigation focuses on whether the Silicon Motion Board breached its fiduciary duties to shareholders by failing to conduct due process and whether MaxLinear is paying too little for the company.

Additional information can be found at https://www.brodskysmith.com/cases/silicon-motion-technology-corporation-nasdaq-simo/

Brodsky & Smith is a litigation law firm with extensive expertise in representing shareholders across the country in securities lawsuits and class actions. Brodsky & Smith attorneys have been appointed by numerous courts across the country to serve as lead counsel in class action lawsuits and have successfully recovered millions of dollars for our clients and shareholders. Lawyer advertisement. Previous results do not guarantee a similar result.

Brodsky-Smith-LLC.png